Lilly’s Olmorasib Gets US FDA’s Breakthrough Therapy Status For Multi-Purpose Cancer Drug
Lilly’s Olmorasib Gets US FDA’s Breakthrough Therapy Status For Multi-Purpose Cancer Drug
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Lilly’s Olmorasib Gets US FDA’s Breakthrough Therapy Status For Multi-Purpose Cancer Drug